5-HT1A receptor ligands and their therapeutic applications: review of new patents
Sign Up to like & getrecommendations! Published in 2018 at "Expert Opinion on Therapeutic Patents"
DOI: 10.1080/13543776.2018.1514011
Abstract: ABSTRACT Introduction: 5-HT1AR was one of the first discovered serotonin receptors and is one of the most thoroughly studied. Dysfunctions associated with 5-HT1AR neurotransmission are linked to several psychiatric disorders, including anxiety, depression, and movement… read more here.
Keywords: applications review; ligands therapeutic; ht1a receptor; therapeutic applications ... See more keywords